{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:46:44Z","timestamp":1793969204198,"version":"4.8.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1100626"],"award-info":[{"award-number":["1100626"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1162349"],"award-info":[{"award-number":["1162349"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2002660"],"award-info":[{"award-number":["2002660"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DP210102837"],"award-info":[{"award-number":["DP210102837"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The risk for dementia increases exponentially from the seventh decade of life. Identifying and understanding the biochemical changes that sensitize the ageing brain to neurodegeneration will provide new opportunities for dementia prevention and treatment. This study aimed to determine how ageing and major genetic risk factors for dementia affect the hippocampal proteome and lipidome of neurologically-normal humans over the age of 65. The hippocampus was chosen as it is highly susceptible to atrophy with ageing and in several neurodegenerative diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Mass spectrometry-based proteomic and lipidomic analysis of CA1 hippocampus samples from 74 neurologically normal human donors, aged 66\u2013104, was used in combination with multiple regression models and gene set enrichment analysis to identify age-dependent changes in the proteome and lipidome. ANOVA was used to test the effect of major dementia risk alleles in the\n                      <jats:italic>TMEM106B<\/jats:italic>\n                      and\n                      <jats:italic>APOE<\/jats:italic>\n                      genes on the hippocampal proteome and lipidome, adjusting for age, gender, and post-mortem interval. Fibrillar C-terminal TMEM106B fragments were isolated using sarkosyl fractionation and quantified by immunoblotting.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Forty proteins were associated with age at false discovery rate-corrected P\u2009&lt;\u20090.05, including proteins that regulate cell adhesion, the cytoskeleton, amino acid and lipid metabolism, and ribosomal subunits. TMEM106B, a regulator of lysosomal and oligodendrocyte function, was regulated with greatest effect size. The increase in TMEM106B levels with ageing was specific to carriers of the rs1990622-A allele in the\n                      <jats:italic>TMEM106B<\/jats:italic>\n                      gene that increases risk for frontotemporal dementia, Alzheimer\u2019s disease, Parkinson\u2019s disease, and hippocampal sclerosis with ageing. Rs1990622-A was also associated with higher TMEM106B fibril content. Hippocampal lipids were not significantly affected by\n                      <jats:italic>APOE<\/jats:italic>\n                      genotype, however levels of myelin-enriched sulfatides and hexosylceramides were significantly lower, and polyunsaturated phospholipids were higher, in rs1990622-A carriers after controlling for\n                      <jats:italic>APOE<\/jats:italic>\n                      genotype.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Our study demonstrates that TMEM106B protein abundance is increased with brain ageing in humans, establishes that dementia risk allele rs1990622-A predisposes to TMEM106B fibril formation in the hippocampus, and provides the first evidence that rs1990622-A affects brain lipid homeostasis, particularly myelin lipids. Our data suggests that\n                      <jats:italic>TMEM106B<\/jats:italic>\n                      is one of a growing list of major dementia risk genes that affect glial lipid metabolism.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13024-023-00650-3","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T15:01:54Z","timestamp":1695135714000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["The major TMEM106B dementia risk allele affects TMEM106B protein levels, fibril formation, and myelin lipid homeostasis in the ageing human hippocampus"],"prefix":"10.1186","volume":"18","author":[{"given":"Jun Yup","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan J","family":"Harney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D","family":"Teo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B","family":"Kwok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg T.","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Larance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1655-1184","authenticated-orcid":false,"given":"Anthony S","family":"Don","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,19]]},"reference":[{"key":"650_CR1","unstructured":"Global_Burden_of_Disease_Dementia_Collaborators. Global, regional, and national burden of Alzheimer\u2019s disease and other dementias, 1990\u20132016: a systematic analysis for the global burden of Disease Study 2016. Lancet Neurol. 2019;18(1):88\u2013106."},{"issue":"4","key":"650_CR2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82(4):239\u201359.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"650_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0197-4580(96)00213-8","volume":"18","author":"MJ De Leon","year":"1997","unstructured":"De Leon MJ, George AE, Golomb J, Tarshish C, Convit A, Kluger A, et al. Frequency of hippocampal formation atrophy in normal aging and Alzheimer\u2019s disease. Neurobiol Aging. 1997;18(1):1\u201311.","journal-title":"Neurobiol Aging"},{"issue":"6","key":"650_CR4","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1093\/brain\/awz099","volume":"142","author":"PT Nelson","year":"2019","unstructured":"Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K, et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain. 2019;142(6):1503\u201327.","journal-title":"Brain"},{"issue":"2","key":"650_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00401-013-1154-1","volume":"126","author":"PT Nelson","year":"2013","unstructured":"Nelson PT, Smith CD, Abner EL, Wilfred BJ, Wang WX, Neltner JH, et al. Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease. Acta Neuropathol. 2013;126(2):161\u201377.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"650_CR6","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1136\/jnnp.2005.075341","volume":"77","author":"LA van de Pol","year":"2006","unstructured":"van de Pol LA, Hensel A, van der Flier WM, Visser PJ, Pijnenburg YA, Barkhof F, et al. Hippocampal atrophy on MRI in frontotemporal lobar degeneration and Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry. 2006;77(4):439\u201342.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"650_CR7","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1523\/JNEUROSCI.3047-16.2016","volume":"37","author":"DH Adamowicz","year":"2017","unstructured":"Adamowicz DH, Roy S, Salmon DP, Galasko DR, Hansen LA, Masliah E, et al. Hippocampal alpha-synuclein in dementia with Lewy Bodies contributes to memory impairment and is consistent with spread of Pathology. J Neurosci. 2017;37(7):1675\u201384.","journal-title":"J Neurosci"},{"key":"650_CR8","doi-asserted-by":"publisher","first-page":"101904","DOI":"10.1016\/j.nicl.2019.101904","volume":"23","author":"L Nobis","year":"2019","unstructured":"Nobis L, Manohar SG, Smith SM, Alfaro-Almagro F, Jenkinson M, Mackay CE, et al. Hippocampal volume across age: Nomograms derived from over 19,700 people in UK Biobank. Neuroimage Clin. 2019;23:101904.","journal-title":"Neuroimage Clin"},{"issue":"9","key":"650_CR9","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1001\/archneur.1993.00540090066012","volume":"50","author":"J Golomb","year":"1993","unstructured":"Golomb J, de Leon MJ, Kluger A, George AE, Tarshish C, Ferris SH. Hippocampal atrophy in normal aging. An association with recent memory impairment. Arch Neurol. 1993;50(9):967\u201373.","journal-title":"Arch Neurol"},{"issue":"20","key":"650_CR10","doi-asserted-by":"publisher","first-page":"eabn4437","DOI":"10.1126\/sciadv.abn4437","volume":"8","author":"V Kluever","year":"2022","unstructured":"Kluever V, Russo B, Mandad S, Kumar NH, Alevra M, Ori A, et al. Protein lifetimes in aged brains reveal a proteostatic adaptation linking physiological aging to neurodegeneration. Sci Adv. 2022;8(20):eabn4437.","journal-title":"Sci Adv"},{"issue":"6","key":"650_CR11","doi-asserted-by":"publisher","first-page":"e9596","DOI":"10.15252\/msb.20209596","volume":"16","author":"E Kelmer Sacramento","year":"2020","unstructured":"Kelmer Sacramento E, Kirkpatrick JM, Mazzetto M, Baumgart M, Bartolome A, Di Sanzo S, et al. Reduced proteasome activity in the aging brain results in ribosome stoichiometry loss and aggregation. Mol Syst Biol. 2020;16(6):e9596.","journal-title":"Mol Syst Biol"},{"issue":"11","key":"650_CR12","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1038\/s12276-020-00522-6","volume":"52","author":"S Ham","year":"2020","unstructured":"Ham S, Lee SV. Advances in transcriptome analysis of human brain aging. Exp Mol Med. 2020;52(11):1787\u201397.","journal-title":"Exp Mol Med"},{"issue":"6994","key":"650_CR13","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/nature02661","volume":"429","author":"T Lu","year":"2004","unstructured":"Lu T, Pan Y, Kao SY, Li C, Kohane I, Chan J, et al. Gene regulation and DNA damage in the ageing human brain. Nature. 2004;429(6994):883\u201391.","journal-title":"Nature"},{"issue":"7","key":"650_CR14","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1089\/omi.2022.0053","volume":"26","author":"P Mol","year":"2022","unstructured":"Mol P, Chatterjee O, Gopalakrishnan L, Mangalaparthi KK, Bhat F, Kumar M, et al. Age-Associated Molecular Changes in Human Hippocampus Subfields as determined by quantitative proteomics. OMICS. 2022;26(7):382\u201391.","journal-title":"OMICS"},{"issue":"1","key":"650_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12868-020-0550-4","volume":"21","author":"S Meng","year":"2020","unstructured":"Meng S, Xia W, Pan M, Jia Y, He Z, Ge W. Proteomics profiling and pathway analysis of hippocampal aging in rhesus monkeys. BMC Neurosci. 2020;21(1):2.","journal-title":"BMC Neurosci"},{"key":"650_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.exger.2018.07.002","volume":"111","author":"HS Hamezah","year":"2018","unstructured":"Hamezah HS, Durani LW, Yanagisawa D, Ibrahim NF, Aizat WM, Bellier JP, et al. Proteome profiling in the hippocampus, medial prefrontal cortex, and striatum of aging rat. Exp Gerontol. 2018;111:53\u201364.","journal-title":"Exp Gerontol"},{"key":"650_CR17","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.neurobiolaging.2015.11.029","volume":"39","author":"B Xu","year":"2016","unstructured":"Xu B, Gao Y, Zhan S, Xiong F, Qiu W, Qian X, et al. Quantitative protein profiling of hippocampus during human aging. Neurobiol Aging. 2016;39:46\u201356.","journal-title":"Neurobiol Aging"},{"issue":"5","key":"650_CR18","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41591-020-0815-6","volume":"26","author":"ECB Johnson","year":"2020","unstructured":"Johnson ECB, Dammer EB, Duong DM, Ping L, Zhou M, Yin L, et al. Large-scale proteomic analysis of Alzheimer\u2019s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nat Med. 2020;26(5):769\u201380.","journal-title":"Nat Med"},{"issue":"1","key":"650_CR19","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1038\/s41467-019-09613-z","volume":"10","author":"AP Wingo","year":"2019","unstructured":"Wingo AP, Dammer EB, Breen MS, Logsdon BA, Duong DM, Troncosco JC, et al. Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age. Nat Commun. 2019;10(1):1619.","journal-title":"Nat Commun"},{"issue":"4","key":"650_CR20","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0022-2275(20)39619-X","volume":"6","author":"JS O\u2019Brien","year":"1965","unstructured":"O\u2019Brien JS, Sampson EL. Lipid composition of the normal human brain: gray matter, white matter, and myelin. J Lipid Res. 1965;6(4):537\u201344.","journal-title":"J Lipid Res"},{"issue":"12","key":"650_CR21","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/j.bbalip.2017.08.008","volume":"1862","author":"V Vozella","year":"2017","unstructured":"Vozella V, Basit A, Misto A, Piomelli D. Age-dependent changes in nervonic acid-containing sphingolipids in mouse hippocampus. Biochim Biophys Acta Mol Cell Biol Lipids. 2017;1862(12):1502\u201311.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"7","key":"650_CR22","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1073\/pnas.0305799101","volume":"101","author":"RG Cutler","year":"2004","unstructured":"Cutler RG, Kelly J, Storie K, Pedersen WA, Tammara A, Hatanpaa K, et al. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2004;101(7):2070\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"650_CR23","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.neurobiolaging.2009.08.007","volume":"32","author":"G Bartzokis","year":"2011","unstructured":"Bartzokis G. Alzheimer\u2019s disease as homeostatic responses to age-related myelin breakdown. Neurobiol Aging. 2011;32(8):1341\u201371.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"650_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","volume":"8","author":"BT Hyman","year":"2012","unstructured":"Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, et al. National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease. Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc. 2012;8(1):1\u201313.","journal-title":"Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc"},{"issue":"2","key":"650_CR25","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3233\/JAD-171054","volume":"63","author":"TA Couttas","year":"2018","unstructured":"Couttas TA, Kain N, Tran C, Chatterton Z, Kwok JB, Don AS. Age-dependent changes to Sphingolipid Balance in the human Hippocampus are gender-specific and may sensitize to Neurodegeneration. J Alzheimer\u2019s Disease: JAD. 2018;63(2):503\u201314.","journal-title":"J Alzheimer\u2019s Disease: JAD"},{"issue":"1","key":"650_CR26","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0003-2697(84)90782-6","volume":"138","author":"D Wessel","year":"1984","unstructured":"Wessel D, Flugge UI. A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal Biochem. 1984;138(1):141\u20133.","journal-title":"Anal Biochem"},{"issue":"5","key":"650_CR27","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1021\/acs.jproteome.9b00090","volume":"18","author":"DJ Harney","year":"2019","unstructured":"Harney DJ, Hutchison AT, Hatchwell L, Humphrey SJ, James DE, Hocking S, et al. Proteomic analysis of human plasma during intermittent fasting. J Proteome Res. 2019;18(5):2228\u201340.","journal-title":"J Proteome Res"},{"key":"650_CR28","doi-asserted-by":"crossref","unstructured":"Diner I, Nguyen T, Seyfried NT. Enrichment of Detergent-insoluble protein aggregates from human postmortem brain. J Vis Exp. 2017(128).","DOI":"10.3791\/55835"},{"issue":"7909","key":"650_CR29","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41586-022-04650-z","volume":"605","author":"M Schweighauser","year":"2022","unstructured":"Schweighauser M, Arseni D, Bacioglu M, Huang M, Lovestam S, Shi Y, et al. Age-dependent formation of TMEM106B amyloid filaments in human brains. Nature. 2022;605(7909):310\u20134.","journal-title":"Nature"},{"issue":"5","key":"650_CR30","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1074\/mcp.M114.044305","volume":"14","author":"R Bruderer","year":"2015","unstructured":"Bruderer R, Bernhardt OM, Gandhi T, Miladinovic SM, Cheng LY, Messner S, et al. Extending the limits of quantitative proteome profiling with data-independent acquisition and application to acetaminophen-treated three-dimensional liver microtissues. Mol Cell Proteomics. 2015;14(5):1400\u201310.","journal-title":"Mol Cell Proteomics"},{"key":"650_CR31","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3389\/fgene.2020.00157","volume":"11","author":"TA Myers","year":"2020","unstructured":"Myers TA, Chanock SJ, Machiela MJ. LDlinkR: an R Package for rapidly calculating linkage disequilibrium statistics in diverse populations. Front Genet. 2020;11:157.","journal-title":"Front Genet"},{"issue":"7571","key":"650_CR32","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"C Genomes Project","year":"2015","unstructured":"Genomes Project C, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, et al. A global reference for human genetic variation. Nature. 2015;526(7571):68\u201374.","journal-title":"Nature"},{"key":"650_CR33","doi-asserted-by":"crossref","unstructured":"Sambrook J, Russell DW. Purification of nucleic acids by extraction with phenol:chloroform. CSH Protoc. 2006;2006(1).","DOI":"10.1101\/pdb.prot4045"},{"issue":"2","key":"650_CR34","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3390\/metabo5020389","volume":"5","author":"ZH Alshehry","year":"2015","unstructured":"Alshehry ZH, Barlow CK, Weir JM, Zhou Y, McConville MJ, Meikle PJ. An efficient single phase method for the extraction of plasma lipids. Metabolites. 2015;5(2):389\u2013403.","journal-title":"Metabolites"},{"issue":"3","key":"650_CR35","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innov (Camb). 2021;2(3):100141.","journal-title":"Innov (Camb)"},{"key":"650_CR36","doi-asserted-by":"crossref","unstructured":"Dammer EB, Seyfried NT, Johnson ECB. Batch correction and harmonization of -Omics datasets with a tunable median polish of ratio. Front Syst Biol. 2023;3.","DOI":"10.3389\/fsysb.2023.1092341"},{"issue":"1","key":"650_CR37","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41597-020-00650-8","volume":"7","author":"L Ping","year":"2020","unstructured":"Ping L, Kundinger SR, Duong DM, Yin L, Gearing M, Lah JJ, et al. Global quantitative analysis of the human brain proteome and phosphoproteome in Alzheimer\u2019s disease. Sci Data. 2020;7(1):315.","journal-title":"Sci Data"},{"issue":"7370","key":"650_CR38","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nature10524","volume":"478","author":"C Colantuoni","year":"2011","unstructured":"Colantuoni C, Lipska BK, Ye T, Hyde TM, Tao R, Leek JT, et al. Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature. 2011;478(7370):519\u201323.","journal-title":"Nature"},{"issue":"1","key":"650_CR39","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s40478-023-01544-7","volume":"11","author":"OC Marian","year":"2023","unstructured":"Marian OC, Teo JD, Lee JY, Song H, Kwok JB, Landin-Romero R, et al. Disrupted myelin lipid metabolism differentiates frontotemporal dementia caused by GRN and C9orf72 gene mutations. Acta Neuropathol Commun. 2023;11(1):52.","journal-title":"Acta Neuropathol Commun"},{"issue":"12","key":"650_CR40","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1093\/brain\/awx314","volume":"140","author":"C Simons","year":"2017","unstructured":"Simons C, Dyment D, Bent SJ, Crawford J, D\u2019Hooghe M, Kohlschutter A, et al. A recurrent de novo mutation in TMEM106B causes hypomyelinating leukodystrophy. Brain. 2017;140(12):3105\u201311.","journal-title":"Brain"},{"issue":"7","key":"650_CR41","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1093\/brain\/awaa154","volume":"143","author":"T Feng","year":"2020","unstructured":"Feng T, Sheng RR, Sole-Domenech S, Ullah M, Zhou X, Mendoza CS, et al. A role of the frontotemporal lobar degeneration risk factor TMEM106B in myelination. Brain. 2020;143(7):2255\u201371.","journal-title":"Brain"},{"issue":"6","key":"650_CR42","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1093\/brain\/awaa141","volume":"143","author":"X Zhou","year":"2020","unstructured":"Zhou X, Nicholson AM, Ren Y, Brooks M, Jiang P, Zuberi A, et al. Loss of TMEM106B leads to myelination deficits: implications for frontotemporal dementia treatment strategies. Brain. 2020;143(6):1905\u201319.","journal-title":"Brain"},{"issue":"3","key":"650_CR43","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00401-020-02246-3","volume":"141","author":"T Feng","year":"2021","unstructured":"Feng T, Lacrampe A, Hu F. Physiological and pathological functions of TMEM106B: a gene associated with brain aging and multiple brain disorders. Acta Neuropathol. 2021;141(3):327\u201339.","journal-title":"Acta Neuropathol"},{"issue":"5","key":"650_CR44","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.ajhg.2017.09.004","volume":"101","author":"MD Gallagher","year":"2017","unstructured":"Gallagher MD, Posavi M, Huang P, Unger TL, Berlyand Y, Gruenewald AL, et al. A Dementia-Associated risk variant near TMEM106B alters chromatin Architecture and Gene expression. Am J Hum Genet. 2017;101(5):643\u201363.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"650_CR45","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1093\/hmg\/dds475","volume":"22","author":"OA Brady","year":"2013","unstructured":"Brady OA, Zheng Y, Murphy K, Huang M, Hu F. The frontotemporal lobar degeneration risk factor, TMEM106B, regulates lysosomal morphology and function. Hum Mol Genet. 2013;22(4):685\u201395.","journal-title":"Hum Mol Genet"},{"issue":"33","key":"650_CR46","doi-asserted-by":"publisher","first-page":"11213","DOI":"10.1523\/JNEUROSCI.0521-12.2012","volume":"32","author":"AS Chen-Plotkin","year":"2012","unstructured":"Chen-Plotkin AS, Unger TL, Gallagher MD, Bill E, Kwong LK, Volpicelli-Daley L, et al. TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132\/212 cluster and affects progranulin pathways. J Neuroscience: Official J Soc Neurosci. 2012;32(33):11213\u201327.","journal-title":"J Neuroscience: Official J Soc Neurosci"},{"issue":"8","key":"650_CR47","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.cell.2022.02.026","volume":"185","author":"A Chang","year":"2022","unstructured":"Chang A, Xiang X, Wang J, Lee C, Arakhamia T, Simjanoska M, et al. Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases. Cell. 2022;185(8):1346\u201355. e15.","journal-title":"Cell"},{"issue":"7909","key":"650_CR48","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41586-022-04670-9","volume":"605","author":"YX Jiang","year":"2022","unstructured":"Jiang YX, Cao Q, Sawaya MR, Abskharon R, Ge P, DeTure M, et al. Amyloid fibrils in FTLD-TDP are composed of TMEM106B and not TDP-43. Nature. 2022;605(7909):304\u20139.","journal-title":"Nature"},{"issue":"5","key":"650_CR49","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1001\/archneurol.2010.350","volume":"68","author":"C Cruchaga","year":"2011","unstructured":"Cruchaga C, Graff C, Chiang HH, Wang J, Hinrichs AL, Spiegel N, et al. Association of TMEM106B gene polymorphism with age at onset in granulin mutation carriers and plasma granulin protein levels. Arch Neurol. 2011;68(5):581\u20136.","journal-title":"Arch Neurol"},{"issue":"3","key":"650_CR50","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/ng.536","volume":"42","author":"VM Van Deerlin","year":"2010","unstructured":"Van Deerlin VM, Sleiman PM, Martinez-Lage M, Chen-Plotkin A, Wang LS, Graff-Radford NR, et al. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet. 2010;42(3):234\u20139.","journal-title":"Nat Genet"},{"key":"650_CR51","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awad133","volume-title":"C-terminal TMEM106B fragments in human brain correlate with disease-associated TMEM106B haplotypes","author":"CT Vicente","year":"2023","unstructured":"Vicente CT, Perneel J, Wynants S, Heeman B, Van den Broeck M, Baker M, et al. C-terminal TMEM106B fragments in human brain correlate with disease-associated TMEM106B haplotypes. Brain: a journal of neurology; 2023."},{"issue":"10","key":"650_CR52","doi-asserted-by":"publisher","first-page":"e50241","DOI":"10.15252\/embr.202050241","volume":"21","author":"G Werner","year":"2020","unstructured":"Werner G, Damme M, Schludi M, Gnorich J, Wind K, Fellerer K, et al. Loss of TMEM106B potentiates lysosomal and FTLD-like pathology in progranulin-deficient mice. EMBO Rep. 2020;21(10):e50241.","journal-title":"EMBO Rep"},{"issue":"10","key":"650_CR53","doi-asserted-by":"publisher","first-page":"e50197","DOI":"10.15252\/embr.202050197","volume":"21","author":"X Zhou","year":"2020","unstructured":"Zhou X, Brooks M, Jiang P, Koga S, Zuberi AR, Baker MC, et al. Loss of Tmem106b exacerbates FTLD pathologies and causes motor deficits in progranulin-deficient mice. EMBO Rep. 2020;21(10):e50197.","journal-title":"EMBO Rep"},{"issue":"3","key":"650_CR54","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1083\/jcb.201305076","volume":"203","author":"MD Huber","year":"2013","unstructured":"Huber MD, Vesely PW, Datta K, Gerace L. Erlins restrict SREBP activation in the ER and regulate cellular cholesterol homeostasis. J Cell Biol. 2013;203(3):427\u201336.","journal-title":"J Cell Biol"},{"key":"650_CR55","doi-asserted-by":"publisher","first-page":"15024","DOI":"10.1038\/celldisc.2015.24","volume":"1","author":"X Zhang","year":"2015","unstructured":"Zhang X, Cai J, Zheng Z, Polin L, Lin Z, Dandekar A, et al. A novel ER-microtubule-binding protein, ERLIN2, stabilizes cyclin B1 and regulates cell cycle progression. Cell Discov. 2015;1:15024.","journal-title":"Cell Discov"},{"issue":"Pt A","key":"650_CR56","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jsbmb.2015.09.041","volume":"155","author":"H Stambergova","year":"2016","unstructured":"Stambergova H, Zemanova L, Lundova T, Malcekova B, Skarka A, Safr M, et al. Human DHRS7, promising enzyme in metabolism of steroids and retinoids? J Steroid Biochem Mol Biol. 2016;155(Pt A):112\u20139.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"19","key":"650_CR57","doi-asserted-by":"publisher","first-page":"7482","DOI":"10.1073\/pnas.0601213103","volume":"103","author":"K Aberg","year":"2006","unstructured":"Aberg K, Saetre P, Jareborg N, Jazin E, Human QKI. A potential regulator of mRNA expression of human oligodendrocyte-related genes involved in schizophrenia. Proc Natl Acad Sci U S A. 2006;103(19):7482\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"650_CR58","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1172\/JCI131800","volume":"130","author":"X Zhou","year":"2020","unstructured":"Zhou X, He C, Ren J, Dai C, Stevens SR, Wang Q, et al. Mature myelin maintenance requires Qki to coactivate PPARbeta-RXRalpha-mediated lipid metabolism. J Clin Investig. 2020;130(5):2220\u201336.","journal-title":"J Clin Investig"},{"issue":"7","key":"650_CR59","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1111\/j.1460-9568.2009.06934.x","volume":"30","author":"P Vodrazka","year":"2009","unstructured":"Vodrazka P, Korostylev A, Hirschberg A, Swiercz JM, Worzfeld T, Deng S, et al. The semaphorin 4D-plexin-B signalling complex regulates dendritic and axonal complexity in developing neurons via diverse pathways. Eur J Neurosci. 2009;30(7):1193\u2013208.","journal-title":"Eur J Neurosci"},{"key":"650_CR60","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.mcn.2018.06.008","volume":"92","author":"JE McDermott","year":"2018","unstructured":"McDermott JE, Goldblatt D, Paradis S. Class 4 semaphorins and Plexin-B receptors regulate GABAergic and glutamatergic synapse development in the mammalian hippocampus. Mol Cell Neurosci. 2018;92:50\u201366.","journal-title":"Mol Cell Neurosci"},{"issue":"3","key":"650_CR61","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/77046","volume":"25","author":"CK Lee","year":"2000","unstructured":"Lee CK, Weindruch R, Prolla TA. Gene-expression profile of the ageing brain in mice. Nat Genet. 2000;25(3):294\u20137.","journal-title":"Nat Genet"},{"issue":"4","key":"650_CR62","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1073\/pnas.98.4.1930","volume":"98","author":"CH Jiang","year":"2001","unstructured":"Jiang CH, Tsien JZ, Schultz PG, Hu Y. The effects of aging on gene expression in the hypothalamus and cortex of mice. Proc Natl Acad Sci USA. 2001;98(4):1930\u20134.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"650_CR63","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1073\/pnas.0308512100","volume":"101","author":"EM Blalock","year":"2004","unstructured":"Blalock EM, Geddes JW, Chen KC, Porter NM, Markesbery WR, Landfield PW. Incipient Alzheimer\u2019s disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci USA. 2004;101(7):2173\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"650_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12017-021-08644-4","volume":"23","author":"JY Lee","year":"2021","unstructured":"Lee JY, Marian OC, Don AS. Defective lysosomal lipid catabolism as a common pathogenic mechanism for Dementia. Neuromolecular Med. 2021;23(1):1\u201324.","journal-title":"Neuromolecular Med"},{"issue":"1","key":"650_CR65","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/prot.26201","volume":"90","author":"TP Levine","year":"2022","unstructured":"Levine TP. TMEM106B in humans and Vac7 and Tag1 in yeast are predicted to be lipid transfer proteins. Proteins. 2022;90(1):164\u201375.","journal-title":"Proteins"},{"issue":"4","key":"650_CR66","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/j.1651-2227.1975.tb03896.x","volume":"64","author":"MT Vanier","year":"1975","unstructured":"Vanier MT, Svennerholm L. Chemical pathology of Krabbe\u2019s disease. III. Ceramide-hexosides and gangliosides of brain. Acta Paediatr Scand. 1975;64(4):641\u20138.","journal-title":"Acta Paediatr Scand"},{"issue":"8","key":"650_CR67","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.bbalip.2014.12.016","volume":"1851","author":"S Schmitt","year":"2015","unstructured":"Schmitt S, Castelvetri LC, Simons M. Metabolism and functions of lipids in myelin. Biochim Biophys Acta. 2015;1851(8):999\u20131005.","journal-title":"Biochim Biophys Acta"},{"key":"650_CR68","first-page":"5408452","volume":"2020","author":"Y Li","year":"2020","unstructured":"Li Y, Yu H, Chen C, Li S, Zhang Z, Xu H, et al. Proteomic Profile of Mouse Brain Aging Contributions to mitochondrial dysfunction, DNA oxidative damage, loss of neurotrophic factor, and synaptic and ribosomal proteins. Oxid Med Cell Longev. 2020;2020:5408452.","journal-title":"Oxid Med Cell Longev"},{"issue":"4","key":"650_CR69","doi-asserted-by":"publisher","first-page":"e1002287","DOI":"10.1371\/journal.pmed.1002287","volume":"14","author":"CC White","year":"2017","unstructured":"White CC, Yang HS, Yu L, Chibnik LB, Dawe RJ, Yang J, et al. Identification of genes associated with dissociation of cognitive performance and neuropathological burden: multistep analysis of genetic, epigenetic, and transcriptional data. PLoS Med. 2017;14(4):e1002287.","journal-title":"PLoS Med"},{"issue":"4","key":"650_CR70","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.cels.2017.02.009","volume":"4","author":"H Rhinn","year":"2017","unstructured":"Rhinn H, Abeliovich A. Differential Aging Analysis in Human cerebral cortex identifies variants in TMEM106B and GRN that regulate aging phenotypes. Cell Syst. 2017;4(4):404\u201315. e5.","journal-title":"Cell Syst"},{"issue":"3","key":"650_CR71","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00401-022-02531-3","volume":"145","author":"J Perneel","year":"2023","unstructured":"Perneel J, Neumann M, Heeman B, Cheung S, Van den Broeck M, Wynants S, et al. Accumulation of TMEM106B C-terminal fragments in neurodegenerative disease and aging. Acta Neuropathol. 2023;145(3):285\u2013302.","journal-title":"Acta Neuropathol"},{"key":"650_CR72","doi-asserted-by":"crossref","unstructured":"Nicholson AM, Finch NA, Wojtas A, Baker MC, Perkerson RB 3rd, Castanedes-Casey M, et al. TMEM106B p.T185S regulates TMEM106B protein levels: implications for frontotemporal dementia. J Neurochem. 2013;126(6):781\u201391.","DOI":"10.1111\/jnc.12329"},{"issue":"5","key":"650_CR73","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1212\/WNL.0b013e31820a0e3b","volume":"76","author":"N Finch","year":"2011","unstructured":"Finch N, Carrasquillo MM, Baker M, Rutherford NJ, Coppola G, Dejesus-Hernandez M, et al. TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers. Neurology. 2011;76(5):467\u201374.","journal-title":"Neurology"},{"issue":"1","key":"650_CR74","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-018-0264-6","volume":"13","author":"AE Arrant","year":"2018","unstructured":"Arrant AE, Nicholson AM, Zhou X, Rademakers R, Roberson ED. Partial Tmem106b reduction does not correct abnormalities due to progranulin haploinsufficiency. Mol Neurodegener. 2018;13(1):32.","journal-title":"Mol Neurodegener"},{"issue":"10","key":"650_CR75","doi-asserted-by":"publisher","first-page":"e50219","DOI":"10.15252\/embr.202050219","volume":"21","author":"T Feng","year":"2020","unstructured":"Feng T, Mai S, Roscoe JM, Sheng RR, Ullah M, Zhang J, et al. Loss of TMEM106B and PGRN leads to severe lysosomal abnormalities and neurodegeneration in mice. EMBO Rep. 2020;21(10):e50219.","journal-title":"EMBO Rep"},{"issue":"2","key":"650_CR76","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/bpa.12903","volume":"31","author":"S Stroobants","year":"2021","unstructured":"Stroobants S, D\u2019Hooge R, Damme M. Aged Tmem106b knockout mice display gait deficits in coincidence with Purkinje cell loss and only limited signs of non-motor dysfunction. Brain Pathol. 2021;31(2):223\u201338.","journal-title":"Brain Pathol"},{"issue":"4","key":"650_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0057-6","volume":"50","author":"SH Bae","year":"2018","unstructured":"Bae SH, Kim HW, Shin S, Kim J, Jeong YH, Moon J. Decipher reliable biomarkers of brain aging by integrating literature-based evidence with interactome data. Exp Mol Med. 2018;50(4):1\u201315.","journal-title":"Exp Mol Med"},{"key":"650_CR78","doi-asserted-by":"crossref","unstructured":"Ren J, Dai C, Zhou X, Barnes JA, Chen X, Wang Y et al. Qki is an essential regulator of microglial phagocytosis in demyelination. J Exp Med. 2021;218(1).","DOI":"10.1084\/jem.20190348"},{"issue":"1","key":"650_CR79","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/ana.25266","volume":"84","author":"L Yu","year":"2018","unstructured":"Yu L, Petyuk VA, Gaiteri C, Mostafavi S, Young-Pearse T, Shah RC, et al. Targeted brain proteomics uncover multiple pathways to Alzheimer\u2019s dementia. Ann Neurol. 2018;84(1):78\u201388.","journal-title":"Ann Neurol"},{"issue":"6","key":"650_CR80","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/s41593-018-0154-9","volume":"21","author":"S Mostafavi","year":"2018","unstructured":"Mostafavi S, Gaiteri C, Sullivan SE, White CC, Tasaki S, Xu J, et al. A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer\u2019s disease. Nat Neurosci. 2018;21(6):811\u20139.","journal-title":"Nat Neurosci"},{"key":"650_CR81","doi-asserted-by":"crossref","unstructured":"Manni MM, Tiberti ML, Pagnotta S, Barelli H, Gautier R, Antonny B. Acyl chain asymmetry and polyunsaturation of brain phospholipids facilitate membrane vesiculation without leakage. eLife. 2018;7.","DOI":"10.7554\/eLife.34394"},{"issue":"3","key":"650_CR82","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00702-013-1106-x","volume":"121","author":"RC Lu","year":"2014","unstructured":"Lu RC, Wang H, Tan MS, Yu JT, Tan L. TMEM106B and APOE polymorphisms interact to confer risk for late-onset Alzheimer\u2019s disease in Han Chinese. J Neural Transm (Vienna). 2014;121(3):283\u20137.","journal-title":"J Neural Transm (Vienna)"},{"issue":"D1","key":"650_CR83","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","volume":"50","author":"Y Perez-Riverol","year":"2022","unstructured":"Perez-Riverol Y, Bai J, Bandla C, Garcia-Seisdedos D, Hewapathirana S, Kamatchinathan S, et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 2022;50(D1):D543\u2013D52.","journal-title":"Nucleic Acids Res"}],"updated-by":[{"DOI":"10.1186\/s13024-024-00709-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T00:00:00Z","timestamp":1708992000000}}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-023-00650-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-023-00650-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-023-00650-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T10:11:00Z","timestamp":1709374260000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-023-00650-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,19]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["650"],"URL":"https:\/\/doi.org\/10.1186\/s13024-023-00650-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2392941\/v1","asserted-by":"object"}]},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,19]]},"assertion":[{"value":"19 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13024-024-00709-9","URL":"https:\/\/doi.org\/10.1186\/s13024-024-00709-9","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human tissue was provided by the Queensland Brain Bank, University of Queensland; and New South Wales Brain Tissue Resource Centre (BTRC), University of Sydney. The use of human hippocampus tissue samples from the BTRC and Queensland Brain Bank was approved by the University of Sydney Human Research Ethics Committee, #HREC2016\/801.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"63"}}